Impact of case volume on survival of septic shock in Patients with malignancies

Critical Care Medicine

Volumn 40, Issue 1, 2012, Pages 55-62

  Zuber, Benjamin ^a,c,d   Tran, Thi Chien ^e,f   Aegerter, Philippe ^e,f   Grimaldi, David ^a,c,d   Charpentier, Julien ^a   Guidet, Bertrand ^b,g,h   Mira, Jean Paul ^a,c,d   Pène, Frédéric ^a,c,d  

^a Institut Cochin   (France)

^b HÔPITAL SAINT ANTOINE   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d CNRS   (France)

^e HÔPITAL AMBROISE PARÉ   (France)

^f LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^g SORBONNE UNIVERSITÉ   (France)

^h INSERM   (France)

Author keywords

Cancer; Hematological malignancy; Intensive care unit; Septic shock

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL INFECTION; CANCER PATIENT; CANCER SURVIVAL; COHORT ANALYSIS; DATA BASE; DIGESTIVE SYSTEM CANCER; DISEASE SEVERITY; FEMALE; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE MYELOMA; MYCOSIS; NONHODGKIN LYMPHOMA; OUTCOME ASSESSMENT; PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; SCORING SYSTEM; SEPTIC SHOCK; SIMPLIFIED ACUTE PHYSIOLOGY SCORE II; SOLID TUMOR; UROGENITAL TRACT CANCER; UROSEPSIS;

CHI-SQUARE DISTRIBUTION; FEMALE; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOPLASMS; RETROSPECTIVE STUDIES; SHOCK, SEPTIC; TREATMENT OUTCOME;

EID: 84055173597     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e31822d74ba     Document Type: Article

References (46)

1. Annane D, Aegerter P, Jars-Guincestre MC, et al: Current epidemiology of septic shock: The CUB-Réa Network. Am J Respir Crit Care Med 2003; 168:165-172
2. Dombrovskiy VY, Martin AA, Sunderram J, et al: Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: A trend analysis from 1993 to 2003. Crit Care Med 2007; 35:1244-1250
3. Danai PA, Moss M, Mannino DM, et al: The epidemiology of sepsis in patients with malignancy. Chest 2006; 129:1432-1440
4. Williams MD, Braun LA, Cooper LM, et al: Hospitalized cancer patients with severe sepsis: Analysis of incidence, mortality, and associated costs of care. Crit Care 2004; 8:R291-R298
5. Angus DC, Linde-Zwirble WT, Lidicker J, et al: Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29:1303-1310
6. Guidet B, Aegerter P, Gauzit R, et al: Incidence and impact of organ dysfunctions associated with sepsis. Chest 2005; 127: 942-951
7. Levy MM, Dellinger RP, Townsend SR, et al: The Surviving Sepsis Campaign: Results of an international guideline-based performance improvement program targeting severe sepsis. Crit Care Med 2010; 38:367-374
8. LarchéJ, Azoulay E, Fieux F, et al: Improved survival of critically ill cancer patients with septic shock. Intensive Care Med 2003; 29: 1688-1695
9. Pène F, Percheron S, Lemiale V, et al: Temporal changes in management and outcome of septic shock in patients with malignancies in the intensive care unit. Crit Care Med 2008; 36:690-696
10. Vandijck DM, Benoit DD, Depuydt PO, et al: Impact of recent intravenous chemotherapy on outcome in severe sepsis and septic shock patients with hematological malignancies. Intensive Care Med 2008; 34:847-855
11. Lecuyer L, Chevret S, Guidet B, et al: Case volume and mortality in haematological patients with acute respiratory failure. Eur Respir J 2008; 32:748-754
12. Aegerter P, Auvert B, Buonamico G, et al: [Organization and quality control of a clinical database on intensive care medicine in central and suburban Paris]. Rev Epidemiol Sante Publique 1998; 46:226-237
13. Le Gall JR, Lemeshow S, Saulnier F: A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993; 270:2957-2963
14. Royston P, Ambler G, Sauerbrei W: The use of fractional polynomials to model continuous risk variables in epidemiology. Int J Epidemiol 1999; 28:964-974
15. Austin PC, Grootendorst P, Anderson GM: A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: A Monte Carlo study. Stat Med 2007; 26:734-753
16. Blot F, Guiguet M, Nitenberg G, et al: Prognostic factors for neutropenic patients in an intensive care unit: Respective roles of underlying malignancies and acute organ failures. Eur J Cancer 1997; 33:1031-1037
17. Kress JP, Christenson J, Pohlman AS, et al: Outcomes of critically ill cancer patients in a university hospital setting. Am J Respir Crit Care Med 1999; 160:1957-1961
18. Maschmeyer G, Bertschat FL, Moesta KT, et al: Outcome analysis of 189 consecutive cancer patients referred to the intensive care unit as emergencies during a 2-year period. Eur J Cancer 2003; 39:783-792
19. Soares M, Caruso P, Silva E, et al: Characteristics and outcomes of patients with cancer requiring admission to intensive care units: A prospective multicenter study. Crit Care Med 2010; 38:9-15
20. Brunet F, Lanore JJ, Dhainaut JF, et al: Is intensive care justified for patients with haematological malignancies? Intensive Care Med 1990; 16:291-297
21. Groeger JS, White P Jr, Nierman DM, et al: Outcome for cancer patients requiring mechanical ventilation. J Clin Oncol 1999; 17: 991-997
22. Pène F, Soares M: Can we still refuse ICU admission of patients with hematological malignancies? Intensive Care Med 2008; 34: 790-792
23. Darmon M, Azoulay E: Critical care management of cancer patients: Cause for optimism and need for objectivity. Curr Opin Oncol 2009; 21:318-326
24. Rivers E, Nguyen B, Havstad S, et al: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345:1368-1377
25. Annane D, Sébille V, Charpentier C, et al: Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002; 288: 862-871
26. Van den Berghe G, Wilmer A, Hermans G, et al: Intensive insulin therapy in the medical ICU. N Engl J Med 2006; 354:449-461
27. Bernard GR, Vincent JL, Laterre PF, et al: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344:699-709
28. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network N Engl J Med 2000 342 1301-1308
29. Dellinger RP, Levy MM, Carlet JM, et al: Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008; 36:296-327
30. Ferrer R, Artigas A, Suarez D, et al: Effectiveness of treatments for severe sepsis: A prospective, multicenter, observational study. Am J Respir Crit Care Med 2009; 180: 861-866
31. Levy MM, Dellinger RP, Townsend SR, et al: The Surviving Sepsis Campaign: Results of an international guideline-based performance improvement program targeting severe sepsis. Intensive Care Med 2010; 36: 222-231
32. Kahn JM, Goss CH, Heagerty PJ, et al: Hospital volume and the outcomes of mechanical ventilation. N Engl J Med 2006; 355: 41-50
33. Darmon M, Azoulay E, Fulgencio JP, et al: Procedure volume is one determinant of centre effect in mechanically ventilated patients. Eur Respir J 2011; 37:364-370
34. Glance LG, Li Y, Osler TM, et al: Impact of patient volume on the mortality rate of adult intensive care unit patients. Crit Care Med 2006; 34:1925-1934
35. Peelen L, de Keizer NF, Peek N, et al: The influence of volume and intensive care unit organization on hospital mortality in patients admitted with severe sepsis: A retrospective multicentre cohort study. Crit Care 2007; 11:R40
36. Darmon M, Thiery G, Ciroldi M, et al: Intensive care in patients with newly diagnosed malignancies and a need for cancer chemotherapy. Crit Care Med 2005; 33:2488-2493
37. Benoit DD, Depuydt PO, Vandewoude KH, et al: Outcome in severely ill patients with hematological malignancies who received intravenous chemotherapy in the intensive care unit. Intensive Care Med 2006; 32:93-99
38. Roques S, Parrot A, Lavole A, et al: Sixmonth prognosis of patients with lung cancer admitted to the intensive care unit. Intensive Care Med 2009; 35:2044-2050
39. Azoulay E, Fieux F, Moreau D, et al: Acute monocytic leukemia presenting as acute respiratory failure. Am J Respir Crit Care Med 2003; 167:1329-1333
40. Pène F, Aubron C, Azoulay E, et al: Outcome of critically ill allogeneic hematopoietic stem-cell transplantation recipients: A reappraisal of indications for organ failure supports. J Clin Oncol 2006; 24:643-649
41. Buyse S, Teixeira L, Galicier L, et al: Critical care management of patients with hemophagocytic lymphohistiocytosis. Intensive Care Med 2010; 36:1695-1702
42. Soares M, Salluh JI, Spector N, et al: Characteristics and outcomes of cancer patients requiring mechanical ventilatory support for +24 hrs. Crit Care Med 2005; 33:520-526
43. Peigne V, Rusinová K, Karlin L, et al: Continued survival gains in recent years among critically ill myeloma patients. Intensive Care Med 2009; 35:512-518
44. Massion PB, Dive AM, Doyen C, et al: Prognosis of hematologic malignancies does not predict intensive care unit mortality. Crit Care Med 2002; 30:2260-2270
45. Soares M, Carvalho MS, Salluh JI, et al: Effect of age on survival of critically ill patients with cancer. Crit Care Med 2006; 34:715-721
46. Lecuyer L, Chevret S, Thiery G, et al: The ICU trial: A new admission policy for cancer patients requiring mechanical ventilation. Crit Care Med 2007; 35:808-814